Global Biochips Market Research and Forecast, 2018-2023

  • ID: 3821058
  • Report
  • Region: Global
  • Orion Market Research Private Limited
15 % OFF
until Sep 30th 2018
1 of 5

FEATURED COMPANIES

  • 20/20 Gene Systems, Inc.
  • Biofluidix Gmbh
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Oxford Gene Technology
  • MORE
A biochip is a miniaturized laboratories or microarrays that perform thousands of simultaneous biochemical reactions. Biochips are used to perform multiple tests and enable to achieve higher output and speed. The Market is driven by significant demand in personalized medicine and drug discovery & development due to faster test results and accuracy. Growth & demand of Diagnostic market is boosting the global market. Technological advancement and adoption of automation techniques are creating huge scope for biochips market due to faster results and enhanced efficiency of biochips products. Biochips contain very micro sensors which enable to perform speedier test in short period of time.

Biochips technology is boosted by the growth and advancement of proteomics & genomics market. Additionally, rising life style-oriented diseases such as CVD, CHD, Cancer, Diabetes and other lingering diseases are boosting the biochips market. Certain restraints such as high costs of biochips and stringent government regulations are still some of the major concerns hindering the market. However, various other factors such as Research & Development in human genome project which enable to explore DNA sequencing through biochips is expected to drive the future market growth.

North America has the highest contribution to Global Biochips Market followed by Europe due to significant adoption of Biochips in hospitals, research centers and academic institutes. North America is contributing nearly half of the total market share due to huge adoption of Biochips applications and huge investment in Biochips market. APAC countries such as China, India, Japan and Korea are expected to create huge opportunity for global Biochips market due to huge demand of Biochips application for diagnostics. APAC region is predicted to be a lucrative region due to rising lifestyle-oriented diseases, increase in adoption of biochips in research institutes and hospitals and improved healthcare spending.

The Key players of Global Biochips market include Abbott Laboratories, Bio-Rad Laboratories Inc., Cepheid Inc., Epigem Ltd, GE Healthcare, Illumina, Inc., Lifesensors, Roche Diagnostics, Thermo Fisher Scientific, Inc. and others. R&D, Partnership, product launch and Collaboration are the key winning strategies adopted by Market players across the globe.

Market Segmentation

Global Biochips Market is segmented on the basis of type, fabrication, end user and region. Global Biochips Market by type includes DNA chips market; Lab on Chips and Protein Chips. Global Biochips Market by Fabrication technology includes Microarrays, Micro fluidics market. Global Biochips Market by end user includes Hospitals, Diagnostic centers, Research Institutes, Academic Institutes and other end users.

Global Biochips Market Research and Analysis, By Type
Global Biochips Market Research and Analysis, By Fabrication Technology
Global Biochips Market Research and Analysis, By End-users

Research Methodology:

The market study of biochips market is incorporated by extensive primary and secondary research. Secondary research has been conducted to refine the available data to breakdown the market in various segments, derive total market size, market forecast and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report country level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior and macro-economic factors. Numbers extracted from Secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives, managers, key opinion leaders and industry experts. Primary research brings the authenticity in our reports.

Secondary sources include:

Financial reports of companies involved in the market
Authentic Public Databases
Whitepapers, research-papers and news blogs
Company websites and their product catalogue.
The report provides in-depth analysis on pricing, market size, intended quality of the product preferred by consumers, initial norms and vehicle segment. The report will serve as a source for 360-degree analysis of the market thoroughly integrating different models such as PEST analysis, Porter five analysis delivering insights into the market for better business decisions.

The Report Covers:

Comprehensive research methodology of Global Biochips Market. This report also includes detailed and extensive market overview with Analyst insights & key market trends.
Exhaustive Analysis of macro and micro factors influencing the market guided by key recommendations.
Analysis of regional regulations and other government policies impacting the Global Biochips Market
Insights about market determinants which are stimulating the Global Biochips Market
Detailed and extensive market segments with regional distribution of forecasted revenues.
Extensive profiles and recent developments of market players.
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • 20/20 Gene Systems, Inc.
  • Biofluidix Gmbh
  • Cepheid Inc.
  • Fluidigm Corporation
  • Illumina, Inc.
  • Oxford Gene Technology
  • MORE
1. Report Summary
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
1.2.3. By Stakeholders

2. Market Overview and Insights
2.1. Definition
2.2. Analyst Insights &Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendation
2.2.3. Conclusion
2.3. Regulations
2.3.1. United States
2.3.2. European Union
2.3.3. China
2.3.4. India
2.3.5. Rest of the World

3. Market Determinant
3.1. Motivators
3.1.1. Rise In Demand of Personalized Medicines
3.1.2. Technological Advancement In Biochips Market
3.1.3. Advancement In Proteomics & Genomics
3.1.4. Higher Adoption of Biochips and Growing Applications
3.1.5. R&D In Human Genome Project
3.1.6. Advancement In Drug Discovery & Development
3.1.7. Rising Life Style Oriented Diseases and Other Lingering Diseases
3.2. Restraint
3.2.1. Stringent Regulations and Government Policies
3.2.2. High Cost of Biochips Products
3.3. Opportunity
3.3.1. Baby Biochips To Boost the Chances of Conception In Infertile Couples
3.3.2. Development In Human Genome Project

4. Market Segmentation
4.1. Biochips Market, By Type
4.1.1. Dna Chips Market, By Application
4.1.1.1. Drug Discovery & Development
4.1.1.2. Gene Expression
4.1.1.3. Snp Identification
4.1.1.4. Agricultural Biotechnology
4.1.1.5. Cancer Diagnostic & Treatment
4.1.1.6. Other Biochips
4.1.2. Lab On a Chip Market, By Application
4.1.2.1. Genomics
4.1.2.2. Drug Discovery
4.1.2.3. Proteomics & Genomics
4.1.2.4. Ivd & Poc
4.1.2.5. Clinical Diagnostics
4.1.2.6. Others
4.1.3. Protein Chips Market, By Application
4.1.3.1. Expression Profiling
4.1.3.2. Drug Discovery
4.1.3.3. Proteomics
4.1.3.4. Diagnostics
4.1.3.5. High-Throughput Screening
4.1.3.6. Other Protein Chips
4.1.4. Arrays Market, By Application
4.1.4.1. Cell Arrays
4.1.4.2. Tissue Arrays
4.2. Biochips Market, By Fabrication Technology
4.2.1. Microarrays
4.2.2. Microfluidics
4.3. Biochips Market, By End User
4.3.1. Hospitals
4.3.2. Diagnostic Centres
4.3.3. Research Institutes
4.3.4. Academic Institutes
4.3.5. Other End Users

5. Competitive Landscape
5.1. Strategy Analysis
5.2. Key Company Analysis

6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. United Kingdom
6.2.2. France
6.2.3. Germany
6.2.4. Italy
6.2.5. Spain
6.2.6. Rest of Europe
6.3. Asia Pacific
6.3.1. India
6.3.2. China
6.3.3. Japan
6.4. Rest of the World

7. Company Profiles
7.1. 20/20 Gene Systems, Inc.
7.2. Abbott Laboratories
7.3. Agendia Bv
7.4. Agilent Technologies, Inc.
7.5. Biofluidix Gmbh
7.6. Bio-Rad Laboratories Inc.
7.7. Cellix Ltd.
7.8. Cepheid Inc.
7.9. Customarray, Inc.
7.10. Elim Biopharmceuticals, Inc.
7.11. Epigem Ltd
7.12. Fluidigm Corporation
7.13. Ge Healthcare
7.14. Hologic, Inc.,
7.15. Illumina, Inc.
7.16. Lifesensors
7.17. Luminex Corporation
7.18. Micropoint Bioscience, Inc
7.19. Oxford Gene Technology
7.20. Perkinelmer, Inc.
7.21. Roche Diagnostics
7.22. Menarin Silicon Biosystems
7.23. Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • 20/20 Gene Systems, Inc.
  • Abbott Laboratories
  • Agendia Bv
  • Agilent Technologies, Inc.
  • Biofluidix Gmbh
  • Bio-Rad Laboratories Inc.
  • Cellix Ltd.
  • Cepheid Inc.
  • Customarray, Inc.
  • Elim Biopharmceuticals, Inc.
  • Epigem Ltd
  • Fluidigm Corporation
  • Ge Healthcare
  • Hologic, Inc.,
  • Illumina, Inc.
  • Lifesensors
  • Luminex Corporation
  • Micropoint Bioscience, Inc
  • Oxford Gene Technology
  • Perkinelmer, Inc.
  • Roche Diagnostics
  • Menarin Silicon Biosystems
  • Thermo Fisher Scientific, Inc.
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll